Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	37.57	28.67	62.89	39.02	148.99
Short-Term Investments	108.13	18.57	45.96	133.54	-
Cash & Short-Term Investments	145.7	47.24	108.85	172.56	148.99
Cash Growth	208.44%	-56.60%	-36.92%	15.82%	3244.31%
Accounts Receivable	-	5.9	5.49	1.86	-
Inventory	-	5.31	6.43	1.86	-
Other Current Assets	3.32	2.84	3.83	3.75	2.28
Total Current Assets	149.01	61.29	124.59	180.03	151.27
Net Property, Plant & Equipment	0	7.63	5.97	2.03	0.61
Other Intangible Assets	-	-	-	-	3.81
Other Long-Term Assets	1.81	1.4	1.87	2.18	2.21
Total Assets	150.83	70.32	132.42	184.24	157.91
Accounts Payable	0.92	2.16	5.9	3.52	6.44
Accrued Expenses	13.6	14.65	14.31	14.92	8.7
Current Portion of Leases	-	0.27	0.43	0.39	0.13
Other Current Liabilities	-	-	5.76	-	-
Total Current Liabilities	14.52	17.07	26.4	18.84	15.27
Long-Term Leases	-	0.57	0.83	1.27	0.47
Other Long-Term Liabilities	-	0.2	-	5.76	5.76
Total Long-Term Liabilities	-	0.77	0.83	7.02	6.23
Total Liabilities	14.52	17.84	27.23	25.86	21.5
Common Stock	0	0	0	0	0
Additional Paid-in Capital	489.44	385.11	374.13	361.69	279.09
Accumulated Other Comprehensive Income	0.12	0.02	0.03	-0.12	-
Retained Earnings	-353.25	-332.65	-268.96	-203.2	-142.69
Shareholders' Equity	136.31	52.48	105.2	158.38	136.41
Total Liabilities & Equity	150.83	70.32	132.42	184.24	157.91
Total Debt	0	0.83	1.27	1.66	0.61
Net Cash (Debt)	145.7	46.4	107.58	170.9	148.38
Net Cash Growth	213.97%	-56.87%	-37.05%	15.17%	3326.88%
Net Cash Per Share	2.35	1.72	4.00	7.59	16.63
Book Value	136.31	52.48	105.2	158.38	136.41
Book Value Per Share	2.20	1.94	3.91	7.04	15.29
Tangible Book Value	136.31	52.48	105.2	158.38	132.6
Tangible Book Value Per Share	2.20	1.94	3.91	7.04	14.86

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q